universal influenza vaccine (Changchun BCHT Pharmaceutical)

The universal influenza vaccine (Changchun BCHT Pharmaceutical) is a preclinical vaccine candidate designed to provide broad and durable protection against a wide range of influenza virus strains. Developed by Changchun BCHT Pharmaceutical, this vaccine aims to overcome the limitations of traditional seasonal influenza vaccines, which require annual updates due to antigenic drift. By targeting conserved regions of the influenza virus that are less prone to mutation, the vaccine is intended to elicit an immune response effective against multiple subtypes and lineages of Influenza A and B, potentially offering long-term protection against both seasonal and pandemic strains.

Other names

通用流感疫苗universal influenza vaccineBCHT universal influenza vaccine